The present invention relates to compounds, compositions, and methods, for treating subjects suspected of needing treatment for a Nidovirales virus infection. In certain embodiments, the compounds comprise Nidovirales helicase inhibitors that do not significantly affect helicase ATPase enzymatic activity or nucleic acid binding activity of the helicase.
Issue/Publication date:
02/23/2016
There are no reviews yet.
Be the first to review “Suppression Of Sars Replication By Sars Helicase Inhibitors” Cancel reply
There are no reviews yet.